MicroQuin 

A novel platform technology to treat the World’s Top Diseases

OWNER

Scott Robinson (See Profile)


Sector

Biotech

Stage

Prototyping, preclinical

Country

United Kingdom


Developed 10 therapeutics with proven in vivo efficacy to treat all breast, ovarian, uterine, lung and colorectal cancer

Developed 5 therapeutics with proven efficacy across Influenza A, RSV, Adenovirus, Coronavirus OC43 and Sars-CoV-2

Winner of numerous awards including 2 Technology in Space Awards where we received funding to work with NASA on the ISS

Our therapeutic target is wholly novel and untouched by any pharmaceutical/Biotech company as it was recently discovered

Our therapeutic target is implicated as integral in Parkinson's, Alzheimer's, diabetes, aging, cancer and other areas

IP Type Status Time Countries Link Coverage
Please, choose an option

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 29th March

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar